The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Ginseng for cancer-related fatigue: Update

    This entry goes back to the top of the gueue in light of a new study of sertraline (Zoloft). Read the comment.

    This is the first study to evaluate the Wisconsin species of American ginseng as a possible treatment for cancer-related fatigue.

    After verifying the quality of the herbal product, 282 patients were randomly assigned to one of 4 treatments for 8 weeks.

    • Placebo
    • Wisconsin ginseng 750 mg
    • Wisconsin ginseng 1,000 mg
    • Wisconsin ginseng 2,000 mg

    And, the results with the 2 higher doses.

    • Improved overall energy
    • Higher vitality
    • Less interference with activity from fatigue
    • Improved overall mental, physical, spiritual, and emotional well-being

    Patients receiving the placebo and the lowest dose of ginseng had very little improvement.

    The results are being presented today at the annual meeting of the American Society of Clinical Oncology.

    The bottom line?
    Much research remains to be done before Wisconsin ginseng is integrated into mainstream medicine for this use.

    Dr. Debra Barton, a registered nurse and the study’s primary investigator, is planning another study in hopes of confirming a new treatment option for cancer-related fatigue.

    6/3/07 11:28 JR

    Leave a Comment

    You must be logged in to post a comment.